Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine for primary dysmenorrhea
IRCT20240910062996N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary dysmenorrhea (PD) comparing Nifedipine with Placebo (2 arms). Primary endpoint: Pain. Started Nov 2024; status: completed.
02
Drugs
nifedipine
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20240910062996N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240910062996N1.